A clinical trial to study the effect of single drug, Tukhme Khurfa in patients with heavy menses
Phase 3
Completed
- Conditions
- Health Condition 1: null- Abnormal Uterine Bleeding patients
- Registration Number
- CTRI/2018/03/012593
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Heavy irregular bleeding
Vaginal bleeding increased in amount or duration
Patient affected from istehaza for 3 months
Exclusion Criteria
pregnancy and lactation
systemic, metabolic illness and malignancy
severe aneamia ( <8 gm%)
IUCDs
recent H/O of chikengunia and dengue
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in PBSC score <br/ ><br>Menstrual regulationTimepoint: 4months
- Secondary Outcome Measures
Name Time Method Change in SF-12 score <br/ ><br>Change in HB%Timepoint: 4 months